Solid tumours revised recist guideline version

Critères RECIST version 1 - cepd.fr

Critères RECIST version 1.1 Evaluation de la réponse tumorale (Nouveaux critères RECIST v 1.1) “New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)” E.A.

  Guidelines, Revised, Version, Solid, Steric, Tumours, Recist version, Solid tumours, Revised recist guideline

固形がんの治療効果判定のための 新ガイドライン RECISTガ …

3 固形がんの治療効果判定のための 新ガイドライン（RECISTガイドライン） 改訂版version 1.1 New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

  Guidelines, Revised, Version, Solid, Steric, Tumours, Solid tumours, Revised recist guideline

11. 効果判定とエンドポイントの定義（RECISTv1.1対応）

研究番号とバージョンを入れる→JCOG 0XXX verX.X プロトコールマニュアル11章抜粋（RECISTv1.1対応）_20090917 1/12

Clinical information guide - lenvima.com

Patients with locally recurrent or metastatic RAI-refractory DTC (N=392) All patients must have had radiographic evidence of disease progression within 12 months prior

  Information, Clinical, Clinical information